Beyond Total Other Income Expense Net from 2010 to 2024
| DOCKF Stock | USD 0.02 0 22.70% |
Total Other Income Expense Net | First Reported 2010-12-31 | Previous Quarter -3.5 K | Current Value -3.7 K | Quarterly Volatility 3 M |
Check Beyond Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Beyond Medical's main balance sheet or income statement drivers, such as Discontinued Operations of 122.5 K, Interest Expense of 7.9 K or Interest Income of 6 K, as well as many indicators such as Price To Sales Ratio of 3.49, Dividend Yield of 0.0 or Days Sales Outstanding of 11.75. Beyond financial statements analysis is a perfect complement when working with Beyond Medical Valuation or Volatility modules.
Beyond | Total Other Income Expense Net |
Currently Active Assets on Macroaxis
When determining whether Beyond Medical Techn is a strong investment it is important to analyze Beyond Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Beyond Medical's future performance. For an informed investment choice regarding Beyond Stock, refer to the following important reports:Check out the analysis of Beyond Medical Correlation against competitors. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beyond Medical. If investors know Beyond will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beyond Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.04) | Revenue Per Share (0) | Quarterly Revenue Growth (0.92) | Return On Assets (2.19) | Return On Equity (1.89) |
The market value of Beyond Medical Techn is measured differently than its book value, which is the value of Beyond that is recorded on the company's balance sheet. Investors also form their own opinion of Beyond Medical's value that differs from its market value or its book value, called intrinsic value, which is Beyond Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beyond Medical's market value can be influenced by many factors that don't directly affect Beyond Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beyond Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beyond Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beyond Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.